Citation Impact
Citing Papers
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
The implications of angiogenesis for the biology and therapy of cancer metastasis
1994 Standout
Effect of subthalamic deep brain stimulation on the function of the urinary bladder
2003
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
P-glycoproteins in pathology: The multidrug resistance gene family in humans
1990
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
Clinical utility of telomerase in cancer
2002
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
1994 Standout
Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients
2003
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Global Cancer Statistics, 2002
2005 Standout
Pathophysiology of bladder dysfunction in Parkinson's disease
2011
Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line
1990
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
1993 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Nedaplatin: a cisplatin derivative in cancer chemotherapy
2013
Cushing's syndrome
2015 Standout
Neural Control of the Lower Urinary Tract
1997
Phaeochromocytoma
2005 Standout
Urinary dysfunction in Parkinson's disease: A review
2008
Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma
2003
A Case‐Control Study of Prostatic Cancer With Reference to Dietary Habits
1988
Prolonged IFN-γ–producing NKT response induced with α-galactosylceramide–loaded DCs
2002 StandoutNobel
Bladder and bowel dysfunction in Parkinson’s disease
2008
Multidrug resistance (mdr) genes in human cancer
1991
Large Differences in Testosterone Excretion in Korean and Swedish Men Are Strongly Associated with a UDP-Glucuronosyl Transferase 2B17 Polymorphism
2006
A silicon transporter in rice
2006 StandoutNature
Diagnosis and Management of Autoimmune Hepatitis
2010
Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats
2000
Vitamin D Deficiency
2007 Standout
Fertility Preservation in Adult Male Cancer Patients
2007
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management
2016
Expression of Multidrug Resistance Gene in Human Cancers
1989
Effects of dopaminergic treatment on bladder function in Parkinson's disease
2004
Hormonal suppression for fertility preservation in males and females
2008
Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease
2005
Tamsulosin
1996
The MDM2 gene amplification database
1998
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
2008 Standout
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome
2009
Molecular themes in oncogenesis
1991 StandoutNobel
Laparoscopic adrenalectomy: 100 resections with clinical long-term follow-up
2004
Multidrug Resistance: A Novel Class of Membrane-Associated Transport Proteins is Identified
1991
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
NKT cells: facts, functions and fallacies
2000
Integrative control of the lower urinary tract: preclinical perspective
2006
Body Size and Prostate Cancer: A 20-Year Follow-up Study Among 135006 Swedish Construction Workers
1997
Non-motor features of Parkinson disease
2017 Standout
Serum retinal and prostate cancer
1988
Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6‐hydroxydopamine (6‐OHDA) lesion of the nigrostriatal pathway
2003
Short‐term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing‐off phenomenon
2003
Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption
1990
Cushing's syndrome
2006 Standout
SPECT imaging of the dopamine transporter with [123I]-β-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction
2001
NKT cells — conductors of tumor immunity?
2002
Nutrition and prostate cancer
1996
International trends and patterns of prostate cancer incidence and mortality
2000
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
1996 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Novel approaches to target the microenvironment of bone metastasis
2021
Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence
1992 Standout
Vitamin C and cancer prevention: the epidemiologic evidence
1991
Beta-carotene and animal fats and their relationship to prostate cancer risk. A case—control study
1989
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Uropathic Observations in Mice Expressing a Constitutively Active Point Mutation in the 5-HT3AReceptor Subunit
2004 StandoutNobel
Serum vitamin A and subsequent development of prostate cancer in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study.
1990
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Vasoactive Potential of the B1Bradykinin Receptor in Normotension and Hypertension
2001
Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
1999 StandoutNobel
Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues
1990
ras Oncogenes in Chemical Carcinogenesis
1989
Selective Ability of Mouse CD1 to Present Glycolipids: α-Galactosylceramide Specifically Stimulates Vα14+ NK T Lymphocytes
1998
Normal Blood Pressure and Renal Function in Mice Lacking the Bradykinin B2Receptor
2001
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Telomerase activity, cell proliferation, and cancer
1998 StandoutNobel
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
2004 StandoutNobel
The rate of telomere sequence loss in human leukocytes varies with age
1998 StandoutNobel
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells
1996
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
1998 StandoutScience
A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii.
1989
MDM2 Suppresses p73 Function without Promoting p73 Degradation
1999 StandoutNobel
Mdm-2: “big brother” of p53
1997
Total Synthesis of (+)-Madindoline A and (−)-Madindoline B, Potent, Selective Inhibitors of Interleukin 6. Determination of the Relative and Absolute Configurations
2000 StandoutNobel
Sexual Function following Radical Prostatectomy: Influence of Preservation of Neurovascular Bundles
1991
Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study.
1990
MDMX: a novel p53-binding protein with some functional properties of MDM2.
1996
Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
1993
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
1998
Dietary silicon and bone health
2005
Central nervous targets for the treatment of bladder dysfunction
2013
The biology of cancer metastasis and implications for therapy
1987
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
2003 StandoutNobel
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
IL-6 as a drug discovery target
1998
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
2010 StandoutNobel
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
1999
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Efficient Total Synthesis of Novel Bioactive Microbial Metabolites
2008 StandoutNobel
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Laparoscopic transperitoneal adrenalectomy
2003
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Bone metabolism and disease in chronic kidney disease
2003
Telomerase activity: A biomarker of cell proliferation, not malignant transformation
1997
The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
2006 StandoutNobel
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
2010
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 StandoutScience
Works of O Yoshida being referenced
Removal of silicon, aluminum and beta2-Microglobulin in chronic haemodialysis patients
1991
Silicon transfer during haemodialysis
1990
MDR1 RNA Levels in Human Renal Cell Carcinomas: Correlation With Grade and Prediction of Reversal of Doxorubicin Resistance by Quinidine in Tumor Explants
1989
Does a gonadotropin-releasing hormone analogue prevent cisplatin-induced spermatogenic impairment?
1991
Enhanced Expression of Interleukin-6 in Primary Human Renal Cell Carcinomas
1991
Activation of H-ras Oncogene in Rat Bladder Tumors Induced by N-Butyl-N-(4-hydroxybutyl)nitrosamine1
1988
Sexuality and fertility in long-term survivors of testicular cancer.
1997
Complications of laparoscopic and retroperitoneoscopic adrenalectomies in 370 cases in Japan: a multi-institutional study
2000
The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
1993
Clinical characteristics of autoimmune hepatitis in older aged patients
2006
Involvement of NK1+ CD4- CD8- alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice.
1997
Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
1995
A Case-Control Study of Prostatic Cancer With Reference to Dietary Habits
1988
[Clinical studies on endocrine therapy of prostatic carcinoma (2): Prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses of causes of death and side effects of endocrine therapy].
1990
Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.
1991
[Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].
1992
Stage A prostatic cancer: a comparative study in Japan and the Netherlands
1986
[Clinical efficacy and safety of long-term administration of YM617 for urinary obstruction of the lower urinary tract].
1991
High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats.
1993
Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay.
1984
[Clinical experience of nerve-sparing radical prostatectomy].
1988
Therapeutic Effects of Dopamine D1/D2Receptor Agonists on Detrusor Hyperreflexia in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Parkinsonian Cynomolgus Monkeys
1998
Oncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 Amplification
1994
Detection of Telomerase Activity in Exfoliated Cells in Urine From Patients With Bladder Cancer
1997
Dietary beta-carotene and cancer of the prostate: a case-control study in Kyoto, Japan.
1988
Hallucal ridge counts in patients with Klinefelter's syndrome
1981